Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.64 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | FAAH | O00519 | 2/20 | 0.47 |
| ▸ | F7 | P08709 | 1/20 | 0.42 |
| ▸ | F3 | P13726 | 1/20 | 0.42 |
| ▸ | TTR | P02766 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2618106 | 1.00 | MAPT (0.72) | MAPTALDH1A1HCAR2ATMFAAH | |
| Phosphoric Acid SCHEMBL3668645 | 0.94 | MAPT (0.66) | MAPTALDH1A1HCAR2ATMFAAH | |
| Phosphoric Acid SCHEMBL3668643 | 0.94 | MAPT (0.66) | MAPTALDH1A1HCAR2ATMFAAH | |
| SCHEMBL872986 | 0.94 | MAPT (0.70) | MAPTALDH1A1HCAR2ATMFAAH | |
| SCHEMBL872985 | 0.94 | MAPT (0.70) | MAPTALDH1A1HCAR2ATMFAAH | |
| SCHEMBL27487508 | 0.94 | MAPT (0.70) | MAPTALDH1A1HCAR2ATMFAAH | |
| SCHEMBL4630838 | 0.93 | MAPT (0.64) | MAPTALDH1A1HCAR2ATMFAAH | |
| SCHEMBL4630840 | 0.93 | MAPT (0.64) | MAPTALDH1A1HCAR2ATMFAAH | |
| SCHEMBL25404144 | 0.92 | MAPT (0.68) | MAPTALDH1A1HCAR2FAAHNPSR1 | |
| SCHEMBL11795363 | 0.92 | MAPT (0.68) | MAPTALDH1A1HCAR2FAAHNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4608363-A1 | A COMPOSITION FOR IMPROVING EFFECTIVENESS OF DYE PRECURSORS FOR CHANGE OF COLOUR OF HAIR | Cavinkare Pvt. Ltd (IN) | 2025-09-03 | — | — | EP | claimed |
| WO-2024089704-A1 | A COMPOSITION FOR IMPROVING EFFECTIVENESS OF DYE PRECURSORS FOR CHANGE OF COLOUR OF HAIR | CAVINKARE PVT.LTD. (IN) | 2024-05-02 | — | — | WO | claimed |
| CN-117309954-A | Method for evaluating quality of grass nuts and processing quality of grass nuts and application of grass nuts | 山东省中医药研究院 | 2023-12-29 | — | — | CN | claimed |
| CN-101386588-A | Method for preparing cilastatin acid | ZHUHAI UNITED LAB CO LTD (CN) | 2009-03-18 | — | — | CN | claimed |
| US-20080311054-A1 | Compositions and Methods to Counteract Oral Malodour | GIVAUDAN SA (CH) | 2008-12-18 | — | — | US | claimed |
| US-20080247966-A1 | Compositions and Methods to Counteract Oral Malodour | GIVAUDAN SA (CH) | 2008-10-09 | — | — | US | claimed |
| EP-1937365-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | Givaudan SA (CH) | 2008-07-02 | — | — | EP | claimed |
| CN-101200434-A | Preparation method for (Z)-7-chloro-((S)-2,2-dimethylcyclopropanecarboxamido)-2-heptenoic acid | WISCHEM CO LTD (KR) | 2008-06-18 | — | — | CN | claimed |
| EP-1919566-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | Givaudan SA (CH) | 2008-05-14 | — | — | EP | claimed |
| EP-1474095-A4 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTRE (US) | 2007-11-28 | — | — | EP | claimed |
| WO-2007025401-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | GIVAUDAN SA (CH) | 2007-03-08 | — | — | WO | claimed |
| WO-2007025402-A1 | COMPOSITIONS AND METHODS TO COUNTERACT ORAL MALODOUR | GIVAUDAN SA (CH) | 2007-03-08 | — | — | WO | claimed |
| EP-1474095-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2004-11-10 | — | — | EP | claimed |
| WO-2003061609-A1 | OLFACTORY ADAPTATION AND CROSS-ADAPTING AGENTS TO REDUCE THE PERCEPTION OF BODY ODORS | MONELL CHEMICAL SENSES CENTER (US) | 2003-07-31 | — | — | WO | claimed |
| EP-4608363-A1 | A COMPOSITION FOR IMPROVING EFFECTIVENESS OF DYE PRECURSORS FOR CHANGE OF COLOUR OF HAIR | Cavinkare Pvt. Ltd (IN) | 2025-09-03 | — | — | EP | disclosed |
| WO-2024089704-A1 | A COMPOSITION FOR IMPROVING EFFECTIVENESS OF DYE PRECURSORS FOR CHANGE OF COLOUR OF HAIR | CAVINKARE PVT.LTD. (IN) | 2024-05-02 | — | — | WO | disclosed |
| CN-117309954-A | Method for evaluating quality of grass nuts and processing quality of grass nuts and application of grass nuts | 山东省中医药研究院 | 2023-12-29 | — | — | CN | disclosed |
| CN-1079649-A | Preparation contains the method for the pharmaceutical composition of imidazolyl-alkenoic acids | SMITHKLINE BEECHAM CORP (US) | 1993-12-22 | — | — | CN | disclosed |
| CN-1048038-A | IMIDAZOLYL-ALKENOIC ACIDS | SMITHKLINE BEECHAM CORP (US) | 1990-12-26 | — | — | CN | disclosed |
| US-3953377-A | Ethyl-2-trans-4-cis undecadienoate, ethyl-2-trans-4-cis dodecadienoate and ethyl-2-decadienoate perfume compositions | FIRMENICH S.A. (CH) | 1976-04-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080311054-A1 | Compositions and Methods to Counteract Oral Malodour | TAS2R60, TAS2R40, LPO | MAPT 3014/4885ALDH1A1 1466/4885HCAR2 1404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.